Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
Tags:
SITC
,
Incyte
,
ChemoCentryx
,
Amgen
,
cytokines
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
Tags:
M&A
,
Pfizer
,
Global Blood Therapeutics
,
Amgen
,
ChemoCentryx
,
Novo Nordisk
,
Forma
,
Alcon
,
Aerie Pharmaceuticals
,
Gilead Sciences
,
MiroBio
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Tags:
Amgen
,
patents
,
Supreme Court
,
Repatha
,
Sanofi
,
Regeneron
Amgen CEO Robert Bradway warns Biden's Inflation Reduction Act could blunt future biotech success stories
Fierce Pharma
Thu, 09/15/22 - 11:22 pm
Tags:
Amgen
,
Bob Bradway
,
Pharma CEOs
,
Inflation Reduction Act
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
Tags:
ESMO
,
KRAS inhibitors
,
Relay Therapeutics
,
Regeneron
,
Amgen
,
Deciphera
,
Clovis Oncology
,
Ayala Pharmaceuticals
,
Springworks
,
Mirati Therapeutics
ESMO: Amgen's Lumakras confirmatory lung cancer data are here, fanning KRAS battle flames
Fierce Pharma
Sun, 09/11/22 - 11:07 pm
Tags:
Amgen
,
lung cancer
,
ESMO
,
KRAS inhibitors
Could This Biosimilar Drug Candidate Be a Winner for Amgen?
Motley Fool
Fri, 09/9/22 - 10:57 am
Tags:
Amgen
,
Soliris
,
biosimilars
,
ABP 959
Amgen's Neulasta gains another biosimilar competitor as sales slip
Endpoints
Thu, 09/8/22 - 04:35 pm
Tags:
Amgen
,
Neulasta
,
Fresenius Kabi
,
biosimilars
,
FDA
,
Stimufend
Amgen’s Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod
MedCity News
Wed, 08/31/22 - 10:23 am
Tags:
Amgen
,
Lumakras
,
non-small cell lung cancer
,
clinical trials
Amgen, amid $10B fight with IRS, lands in Senate committee's tax probe
Fierce Pharma
Fri, 08/12/22 - 10:17 am
Tags:
Amgen
,
taxes
,
IRS
,
Senate
Plaque psoriasis and psoriatic arthritis: trials to watch in 2022
Clinical Trials Arena
Tue, 08/9/22 - 06:32 am
Tags:
clinical trials
,
psoriasis
,
psoriatic arthritis
,
Lipidor
,
AKP-02
,
Amgen
,
ABP-654
,
Hengyi
,
HPP-737
,
Galapagos
,
Jyseleca
World Lung – Toxicity scuppers Amgen’s first-line lung hopes
EP Vantage
Mon, 08/8/22 - 09:53 am
Tags:
Amgen
,
World Lung
,
Lumakras
,
non-small cell lung cancer
Amgen takes BiTEs out of pipeline, dropping BCMA, PSMA assets in light of data and competition
Fierce Biotech
Fri, 08/5/22 - 10:42 am
Tags:
Amgen
,
BCMA
,
PSMA
,
Multiple Myeloma
,
bispecific antibodies
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Fierce Pharma
Thu, 08/4/22 - 12:10 pm
Tags:
Amgen
,
M&A
,
patent cliff
,
ChemoCentryx
Weeks after starting, Amgen flashes yellow light on PhIII of $400M eczema bet
Endpoints
Thu, 08/4/22 - 11:03 am
Tags:
Amgen
,
Kyowa Kirin
,
clinical trials
,
AMG 451
,
atopic dermatitis
Drugmakers leap back into fading heart drug market
Beckers Hospital Review
Thu, 07/28/22 - 06:40 pm
Tags:
Bristol Myers Squibb
,
Novartis
,
Merck
,
Alnylam Pharmaceuticals
,
Amgen
,
hypertension
,
cholesterol
Big Pharmas Amgen, BMS shield BigHat from stormy market with $75M funding
Fierce Biotech
Wed, 07/20/22 - 10:01 am
Tags:
BigHat Biosciences
,
funding
,
Amgen
,
Bristol Myers Squibb
Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents
Endpoints
Tue, 07/19/22 - 10:01 pm
Tags:
Amgen
,
GSK
,
Regenxbio
,
Supreme Court
,
innovation
,
patents
Amgen's blockbuster hopeful Lumakras sees slower than expected sales in latest data, analyst says
Endpoints
Mon, 07/11/22 - 05:53 pm
Tags:
Amgen
,
non-small cell lung cancer
,
Lumakras
Amgen-backed Kernal Biologics pops off with $25M for mRNA platform
Fierce Biotech
Thu, 07/7/22 - 06:22 pm
Tags:
Kernal Biologics
,
MRNA
,
Amgen
,
funding
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.